Ranked #2,542 of 8,699 institutional investors
Rhenman & Partners Asset Management AB
Stockholm, V7
$881M
US stock portfolio at live prices · today −$1.3M (−0.14%)
Live prices, last trade 12:14 PM ET
- Value at quarter end (Q3 2026)
- $903M
- Change from Q2 2026
- −$156.5M (−14.77%)
- Positions
- 85 · 14 new, 18 sold out
- Filed
- Nov 12, 2026
Not counted in the ranking: none$116M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesEW 3.21%MRK 3.17%INSM 3.10%GILD 3.05%VRTX 2.91%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| EW Edwards Lifesciences Corporation | 273,000 | $28.3M | 3.21% | Added +5% |
| MRK Merck & Co., Inc. | 206,900 | $27.9M | 3.17% | Reduced −3% |
| INSM Insmed Incorporated | 187,080 | $27.4M | 3.10% | Added +23% |
| GILD Gilead Sciences, Inc. | 159,050 | $26.9M | 3.05% | Reduced −11% |
| VRTX Vertex Pharmaceuticals Incorporated | 48,935 | $25.6M | 2.91% | Added +59% |
| LLY Eli Lilly and Company | 18,875 | $25.6M | 2.90% | Reduced −15% |
| UNH UnitedHealth Group Incorporated | 71,400 | $24.7M | 2.80% | Reduced −24% |
| BIIB Biogen Inc. | 97,050 | $24.2M | 2.75% | Added +2% |
| BMRN BioMarin Pharmaceutical Inc. | 386,900 | $23.7M | 2.69% | Added +33% |
| COR Cencora, Inc. | 62,478 | $21.5M | 2.44% | Added +34% |
| MCK McKesson Corporation | 17,850 | $19.4M | 2.20% | Added +8% |
| CVS CVS Health Corporation | 220,374 | $18.1M | 2.05% | Reduced −21% |
| REGN Regeneron Pharmaceuticals, Inc. | 19,340 | $18.0M | 2.05% | Reduced −29% |
| ABBV AbbVie Inc. | 61,625 | $17.8M | 2.02% | Reduced −36% |
| IOVA Iovance Biotherapeutics, Inc. | 2,502,577 | $17.5M | 1.99% | Added +47% |
| JNJ Johnson & Johnson | 58,500 | $15.9M | 1.80% | Reduced −19% |
| CNC Centene Corporation | 237,481 | $15.5M | 1.76% | Reduced −3% |
| DHR Danaher Corporation | 68,461 | $15.3M | 1.73% | Reduced −15% |
| CRL Charles River Laboratories International, Inc. | 46,800 | $14.7M | 1.66% | Reduced −18% |
| THC Tenet Healthcare Corporation | 52,787 | $13.9M | 1.58% | Reduced −38% |
| PRCT PROCEPT BioRobotics Corporation | 535,000 | $13.7M | 1.56% | Added +55% |
| ISRG Intuitive Surgical, Inc. | 33,500 | $13.6M | 1.54% | Reduced −3% |
| BSX Boston Scientific Corporation | 315,000 | $13.5M | 1.53% | Reduced −30% |
| A Agilent Technologies, Inc. | 78,000 | $13.3M | 1.51% | Added +4% |
| AXSM Axsome Therapeutics, Inc. | 97,735 | $12.8M | 1.46% | Added +55% |
| NBIX Neurocrine Biosciences, Inc. | 81,291 | $12.4M | 1.41% | Reduced −5% |
| BTSG BrightSpring Health Services, Inc. | 192,896 | $12.3M | 1.39% | Added +16% |
| GH Guardant Health, Inc. | 76,250 | $10.9M | 1.24% | Reduced −34% |
| COO The Cooper Companies, Inc. | 181,500 | $10.8M | 1.23% | Added +236% |
| UTHR United Therapeutics Corporation | 19,150 | $10.6M | 1.21% | New |
| TMO Thermo Fisher Scientific Inc. | 15,563 | $10.5M | 1.20% | Reduced −51% |
| ALHC Alignment Healthcare, Inc. | 1,380,295 | $9.1M | 1.03% | Added +38% |
| MIRM Mirum Pharmaceuticals, Inc. | 91,855 | $9.0M | 1.02% | Reduced −34% |
| EHC Encompass Health Corporation | 66,263 | $8.9M | 1.01% | Reduced −11% |
| ERAS Erasca, Inc. | 608,750 | $8.5M | 0.97% | Added +74% |
| PNTG The Pennant Group, Inc. | 236,499 | $8.2M | 0.93% | Reduced −36% |
| AVR Anteris Technologies Global Corp. | 1,538,625 | $7.6M | 0.86% | Unchanged |
| SYRE Spyre Therapeutics, Inc. | 78,600 | $7.4M | 0.84% | Reduced −34% |
| HUM Humana Inc. | 17,000 | $6.8M | 0.77% | New |
| DNTH Dianthus Therapeutics, Inc. | 75,027 | $6.3M | 0.72% | Reduced −13% |
| VERA Vera Therapeutics, Inc. | 242,500 | $6.2M | 0.70% | New |
| TGTX TG Therapeutics, Inc. | 90,500 | $5.8M | 0.66% | Added +1,710% |
| DXCM DexCom, Inc. | 73,000 | $5.8M | 0.66% | Reduced −54% |
| NRIX Nurix Therapeutics, Inc. | 439,500 | $5.7M | 0.65% | Reduced −36% |
| OSCR Oscar Health, Inc. | 220,000 | $5.6M | 0.64% | Reduced −44% |
| RLAY Relay Therapeutics, Inc. | 343,500 | $5.5M | 0.62% | Reduced −39% |
| CYTK Cytokinetics, Incorporated | 102,800 | $5.3M | 0.60% | New |
| ORKA Oruka Therapeutics, Inc. | 55,900 | $5.3M | 0.60% | Reduced −30% |
| VCEL Vericel Corporation | 90,000 | $5.2M | 0.59% | Added +29% |
| GKOS Glaukos Corporation | 22,000 | $5.2M | 0.59% | Reduced −82% |
| ABT Abbott Laboratories | 49,500 | $5.2M | 0.59% | Reduced −48% |
| ARWR Arrowhead Pharmaceuticals, Inc. | 112,500 | $4.8M | 0.55% | Reduced −12% |
| AGL agilon health, inc. | 52,924 | $4.7M | 0.53% | Added +958% |
| WAY Waystar Holding Corp. | 169,151 | $4.5M | 0.51% | Reduced −5% |
| BBIO BridgeBio Pharma, Inc. | 57,100 | $4.4M | 0.50% | Reduced −37% |
| PODD Insulet Corporation | 32,000 | $4.4M | 0.50% | Reduced −24% |
| ALNY Alnylam Pharmaceuticals, Inc. | 25,900 | $3.9M | 0.44% | Added +51% |
| IDYA IDEAYA Biosciences, Inc. | 140,185 | $3.6M | 0.41% | Reduced −59% |
| KURA Kura Oncology, Inc. | 501,050 | $3.6M | 0.40% | Reduced −15% |
| MBX MBX Biosciences, Inc. | 62,000 | $3.2M | 0.36% | Unchanged |
| SNDX Syndax Pharmaceuticals, Inc. | 342,250 | $3.1M | 0.35% | Reduced −39% |
| NKTR Nektar Therapeutics | 98,380 | $3.1M | 0.35% | Reduced −30% |
| GPCR Structure Therapeutics Inc. | 183,300 | $3.0M | 0.34% | Added +26% |
| OCUL Ocular Therapeutix, Inc. | 512,000 | $2.9M | 0.33% | Added +128% |
| KRYS Krystal Biotech, Inc. | 8,225 | $2.6M | 0.29% | Reduced −50% |
| INNV InnovAge Holding Corp. | 279,000 | $2.6M | 0.29% | New |
| ASTH Astrana Health, Inc. | 79,574 | $2.3M | 0.27% | Reduced −33% |
| MDGL Madrigal Pharmaceuticals, Inc. | 5,655 | $2.2M | 0.25% | Reduced −30% |
| SMMT Summit Therapeutics Inc. | 215,000 | $2.2M | 0.25% | New |
| RYTM Rhythm Pharmaceuticals, Inc. | 19,000 | $2.1M | 0.24% | New |
| DNLI Denali Therapeutics Inc. | 113,585 | $2.1M | 0.24% | Reduced −37% |
| ADPT Adaptive Biotechnologies Corporation | 72,500 | $2.0M | 0.23% | New |
| PRVA Privia Health Group, Inc. | 66,000 | $1.7M | 0.19% | Added +32% |
| STOK Stoke Therapeutics, Inc. | 61,000 | $1.7M | 0.19% | Reduced −5% |
| TNGX Tango Therapeutics, Inc. | 60,000 | $1.3M | 0.15% | New |
| XENE Xenon Pharmaceuticals Inc. | 33,700 | $1.3M | 0.14% | Added +1% |
| ENSG The Ensign Group, Inc. | 3,750 | $667K | <0.1% | New |
| SYK Stryker Corporation | 1,000 | $315K | <0.1% | Reduced −98% |
| TXG 10x Genomics, Inc. | 5,300 | $277K | <0.1% | Reduced −38% |
| BBNX Beta Bionics, Inc. | 20,000 | $269K | <0.1% | New |
| CAI Caris Life Sciences, Inc. | 15,000 | $265K | <0.1% | New |
| BRKR Bruker Corporation | 4,500 | $259K | <0.1% | New |
| AMN AMN Healthcare Services, Inc. | 7,200 | $255K | <0.1% | Reduced −95% |
| SION Sionna Therapeutics, Inc. | 87,500 | $251K | <0.1% | Reduced −10% |
| SCI Service Corporation International | 3,200 | $227K | <0.1% | New |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| NTRA Natera, Inc. | 61,050 | $16.8M |
| ELV Elevance Health, Inc. | 34,900 | $14.2M |
| ALGN Align Technology, Inc. | 63,000 | $9.9M |
| CAH Cardinal Health, Inc. | 22,500 | $6.2M |
| MLYS Mineralys Therapeutics, Inc. | 416,371 | $5.8M |
| MEDP Medpace Holdings, Inc. | 8,500 | $5.3M |
| AMGN Amgen Inc. | 11,900 | $5.2M |
| CI The Cigna Group | 17,400 | $4.9M |
| VEEV Veeva Systems Inc. | 17,300 | $4.6M |
| MOH Molina Healthcare, Inc. | 21,857 | $4.5M |
| MLTX MoonLake Immunotherapeutics | 384,800 | $4.2M |
| VKTX Viking Therapeutics, Inc. | 128,000 | $3.2M |
| DOCS Doximity, Inc. | 76,107 | $2.2M |
| IONS Ionis Pharmaceuticals, Inc. | 59,900 | $1.6M |
| MMED MiniMed Group, Inc. | 55,000 | $892K |
| BCAX Bicara Therapeutics Inc. | 88,150 | $782K |
| ATEC Alphatec Holdings, Inc. | 85,000 | $576K |
| TNDM Tandem Diabetes Care, Inc. | 20,000 | $349K |